Lunch & Learn Round Table with MedPharm
Title: Early De-risking in Formulation Development: The Only Way
- Topical formulation development strategies
- Performance testing models for formulation optimization and selection
- New models for de-risking pharmaceutical development for local delivery
Dr Jon Lenn, Chief Technology Officer,
MedPharm
